<code id='6192C65FBE'></code><style id='6192C65FBE'></style>
    • <acronym id='6192C65FBE'></acronym>
      <center id='6192C65FBE'><center id='6192C65FBE'><tfoot id='6192C65FBE'></tfoot></center><abbr id='6192C65FBE'><dir id='6192C65FBE'><tfoot id='6192C65FBE'></tfoot><noframes id='6192C65FBE'>

    • <optgroup id='6192C65FBE'><strike id='6192C65FBE'><sup id='6192C65FBE'></sup></strike><code id='6192C65FBE'></code></optgroup>
        1. <b id='6192C65FBE'><label id='6192C65FBE'><select id='6192C65FBE'><dt id='6192C65FBE'><span id='6192C65FBE'></span></dt></select></label></b><u id='6192C65FBE'></u>
          <i id='6192C65FBE'><strike id='6192C65FBE'><tt id='6192C65FBE'><pre id='6192C65FBE'></pre></tt></strike></i>

          leisure time

          leisure time

          author:Wikipedia    Page View:4
          UnitedHealth Group
          UnitedHealth Group’s Optum will pay $3.3 billion total for the home health giant Amedisys. Jim Mone/AP

          Home health and hospice chain Amedisys has chosen a new corporate owner.

          Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

          advertisement

          Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          comprehensive

          How one medical school became remarkably diverse
          How one medical school became remarkably diverse

          ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

          read more
          Decaf coffee targeted by food safety group under obscure FDA rule
          Decaf coffee targeted by food safety group under obscure FDA rule

          ApichartWeerawong/APWASHINGTON—There’safightbrewingoverthefutureofdecafcoffee.Consumerhealthadvocate

          read more
          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more

          Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

          HyacinthEmpinado/STATNewbiotechnewsletterlaunchingtomorrow.Don’tmissout.Goodmorning,everyone.Damianh